Healthcare provider profile · identity verified

Olivia Martine Danforth, M.D.

Family Practice · ALBANY, OR · NPI 1790211845

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	320	94
Levothyroxine Sodium	Levothyroxine Sodium	278	67
Gabapentin	Gabapentin	236	52
Amlodipine Besylate	Amlodipine Besylate	229	62
Omeprazole	Omeprazole	211	63
Lisinopril	Lisinopril	196	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	167	36
Losartan Potassium	Losartan Potassium	149	39
Metoprolol Succinate	Metoprolol Succinate	147	38
Duloxetine Hcl	Duloxetine Hcl	123	26
Hydrochlorothiazide	Hydrochlorothiazide	115	37
Albuterol Sulfate Hfa	Albuterol Sulfate	113	43
Escitalopram Oxalate	Escitalopram Oxalate	108	22
Tramadol Hcl	Tramadol Hcl	108	28
Metformin Hcl Er	Metformin Hcl	106	32
Fluticasone Propionate	Fluticasone Propionate	102	42
Trazodone Hcl	Trazodone Hcl	102	29
Pregabalin	Pregabalin	101	19
Eliquis	Apixaban	99	20
Pantoprazole Sodium	Pantoprazole Sodium	87	22
Rosuvastatin Calcium	Rosuvastatin Calcium	85	30
Bupropion Xl	Bupropion Hcl	84	25
Furosemide	Furosemide	84	26
Metformin Hcl	Metformin Hcl	83	28
Estradiol	Estradiol	78	28
Potassium Chloride	Potassium Chloride	72	22
Oxycodone Hcl	Oxycodone Hcl	69	15
Tizanidine Hcl	Tizanidine Hcl	65	20
Ozempic	Semaglutide	62	16
Trulicity	Dulaglutide	61	13
Tamsulosin Hcl	Tamsulosin Hcl	60	13
Alendronate Sodium	Alendronate Sodium	59	21
Fluoxetine Hcl	Fluoxetine Hcl	57	17
Jardiance	Empagliflozin	49	suppressed
Diclofenac Sodium	Diclofenac Sodium	48	16
Donepezil Hcl	Donepezil Hcl	47	suppressed
Simvastatin	Simvastatin	46	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	17
Ondansetron Odt	Ondansetron	43	20
Amitriptyline Hcl	Amitriptyline Hcl	42	suppressed
Alprazolam	Alprazolam	41	15
Aripiprazole	Aripiprazole	41	suppressed
Sertraline Hcl	Sertraline Hcl	39	13
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Bupropion Hcl Sr	Bupropion Hcl	36	suppressed
Telmisartan	Telmisartan	36	suppressed
Baclofen	Baclofen	34	11
Montelukast Sodium	Montelukast Sodium	34	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Famotidine	Famotidine	33	12
Lorazepam	Lorazepam	32	15
Lovastatin	Lovastatin	31	suppressed
Lamotrigine	Lamotrigine	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Spironolactone	Spironolactone	30	11
Triamcinolone Acetonide	Triamcinolone Acetonide	30	19
Allopurinol	Allopurinol	29	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Belsomra	Suvorexant	24	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Prednisone	Prednisone	23	11
Synthroid	Levothyroxine Sodium	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Irbesartan	Irbesartan	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Cefdinir	Cefdinir	20	17
Clonidine Hcl	Clonidine Hcl	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Torsemide	Torsemide	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Nystatin	Nystatin	17	suppressed
Progesterone	Progesterone, Micronized	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Naproxen	Naproxen	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Glimepiride	Glimepiride	13	suppressed
Humulin N	Insulin Nph Human Isophane	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Leucovorin Calcium	Leucovorin Calcium	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Linzess	Linaclotide	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Valsartan	Valsartan	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error